Stay informed with the latest litigation news. Explore now

IP Verse

Dr Reddys Laboratories Betapharm Arzneimittel competitive analysis

Latest publications and patents of Dr Reddys Laboratories Betapharm Arzneimittel New

Explore the latest publications and patents granted to Dr Reddys Laboratories Betapharm Arzneimittel, showcasing their recent innovations and technological advancements.

Latest oppositions filed by Dr Reddys Laboratories Betapharm Arzneimittel

Explore patent oppositions filed by Dr Reddys Laboratories Betapharm Arzneimittel against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 18, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP2959894	S1P Receptor Modulators For Treating Multiple Sclerosis	NOVARTIS	Jul 12, 2023
EP2493466	Novel Antitumoral Use Of Cabazitaxel	AVENTIS PHARMA	Mar 31, 2021
EP3294285	Cabazitaxel And Its Use For Treating Cancer	AVENTIS PHARMA	Aug 26, 2020
EP3351246	Rapamycin Derivative For The Treatment Of A Solid Tumor Associated With Deregulated Angiogenesis	NOVARTIS	Jan 29, 2020
EP3342411	Rapamycin Derivative For Treating Pancreas Cancer	NOVARTIS	Aug 27, 2019
EP3078667	Formulation Of Boronic Acid Compounds	THE UNITED STATES OF AMERICA	Aug 20, 2019

Latest PTAB cases involving Dr Reddys Laboratories Betapharm Arzneimittel New

Discover the latest PTAB cases involving Dr Reddys Laboratories Betapharm Arzneimittel, highlighting their recent legal challenges and patent disputes.